Result Management Process

5.1 Authority to Test
All Athletes under the jurisdiction of a National Federation shall be subject to In-Competition Testing and Out of
competition testing by
a) IBU,
b) the Athlete's National Federation,
c) and any other Anti-Doping Organization responsible for Testing at a IBU Competition or Event in which they
participate.
[Comment to Article 5.1: Target Testing is specified because random Testing, or even weighted random Testing, does not ensure that all of the appropriate Athletes will be tested (e.g., world-class Athletes, Athletes whose performances have dramatically improved over a short period of time, Athletes whose coaches have had other
Athletes test positive, etc.). Obviously, Target Testing must not be used for any purposes other than legitimate Doping Control. The Code makes it clear that Athletes have no right to expect that they will be tested only on a random basis. Similarly, it does not impose any reasonable suspicion or probable cause requirement for Target
Testing]

5.2 Responsibility for IBU Testing
The IBU Medical Committee shall be responsible for drawing up a test distribution plan for the sport of biathlon in accordance with Article 4 of the International Standard for Testing, and for the implementation of that plan, including overseeing all Testing conducted by or on behalf of IBU. Testing may be conducted by members of the IBU Medical Committee, IBU Medical Assistants or by other qualified persons so authorized by IBU.

5.2.1. Without any advanced notice , the IBU has the right to carry out Doping Controls, with and without the assistance of WADA or other organizations specialised in carrying out Doping Controls as agreed with them, of Athletes, including banned or suspended Athletes of IBU member federation are obliged to support the work of the IBU, especially by securing that the selected Athletes are available for testing at the announced place or providing all necessary information, including information on their training schedules, giving dates and locations.

5.2.2. IBU Doping Controls can be conducted at all IBU events as decided by the IBU Executive board, based on a recommendation by the IBU Medical Committee. The recommendation of the IBU MC is to be coordinated with the IBU TC. They must be conducted at OWG, WCH, Y/J WCH, OECH U 26 and WC.

5.2.3. In addition, the NFs are entitled to carry out further Doping Controls applying these Rules. If there is an anti – doping rule violation, this must be immediately reported to the IBU SG and medical committee chair. This report must include the facts of the case, the substance or method that caused the infraction and all
other respective decisions.

5.2.4. Out-of-Competition Doping Controls
Out-of-Competition Doping Controls are subject to these Rules and shall be conducted by agents of WADA or Persons or entities (hereafter “authorised agents”) authorized by the IBU. Such Doping Controls can also be conducted by IBU MDs.

5.2.4.1 Selection procedure for OOCT The chairperson of the IBU MC shall select the nation and the names of the Athletes to be tested. Names and location of all athletes belonging to the IBU RTP have to be provided according to Art. 11.3 of the International Standard for Testing.

1. Athlete waives B sample

Disciplinary Process initiated according to IBU Anti – Doping Rules

• a. B sample to be analysed as soon as possible in laboratory that analysed A sample (ISL)

• b. B sample confirms A sample

  Disciplinary Process initiated according to IBU Anti – Doping Rules initiated

• c. B sample does not confirm A sample, the entire test shall be considered negative; no further disciplinary steps to be taken

3. A Provisional suspension will be implied if the A sample has resulted in an AAF for a prohibited substance that:

• is not a specified substance (Prohibited List)
• and no applicable TUE exists
• and no departure from the International Standard for Testing or the International Standard for Laboratories is reviewed

AAF ‐ Adverse Analytical Finding.
A report from a laboratory or other approved Testing entity that identifies in a Sample the presence of a Prohibited Substance or its Metabolites or Markers (including elevated quantities of endogenous substances) or evidence of the Use of a Prohibited Method.

ADO ‐ Anti‐Doping Organization.
A Signatory that is responsible for adopting rules for initiating, implementing or enforcing any part of the Doping Control process. This includes, for example, the International Olympic Committee, the International Paralympic Committee, other Major Event Organizations that conduct Testing at their Events, WADA, International Federations, and National Anti‐Doping Organizations.

ADR - Anti - Doping Rules

ADRV - Anti - Doping Rule Violation

CAS - The Court of Arbitration for Sports in Lausanne

Consequences of anti‐doping rule violations.
An Athlete's or other Person's violation of an anti‐doping rule may result in one or more of
the following:

• (a) Disqualification means the Athlete's results in a particular Competition or Event are invalidated, with all resulting consequences including forfeiture of any medals, points and prizes;
• (b) Ineligibility means the Athlete or other Person is barred for a specified period of time from participating in any Competition or other activity or funding as provided in Article 10.9; and
• (c) Provisional Suspension means the Athlete or other Person is barred temporarily from participating in any Competition prior to the final decision at a hearing conducted under Article 8 (Right to a Fair Hearing).

In‐Competition. Unless provided otherwise in the rules of an International Federation ( Art. 5.1.1. of the IBU ADR) or other relevant Anti‐Doping Organization, “In‐Competition” means the period commencing twelve hours before a Competition in which the Athlete is scheduled to participate through the end of such Competition and the Sample collection process related to such Competition.

International Standard. A standard adopted by WADA in support of the Code. Compliance with an International Standard (as opposed to another alternative standard, practice or procedure) shall be sufficient to conclude that the procedures addressed by the International Standard were performed properly. International Standards shall include any Technical Documents issued pursuant to the International Standard.

ISL – International Standard for Laboratories

IST – International Standard for Testing

Out‐of‐Competition. Any Doping Control which is not In‐Competition.

Provisional Suspension. See Consequences above. Publicly Disclose or Publicly Report. To disseminate or distribute information to the general public or persons beyond those persons entitled to earlier notification in accordance with Article 15 IBU ADR.

Registered Testing Pool. The pool of top level Athletes established separately by each International Federation and National Anti‐Doping Organization who are subject to both In-Competition and Out-of-Competition Testing as part of that International Federation's or National Anti‐Doping Organization's test distribution plan.

Sample. Any biological material collected for the purposes of Doping Control.
[Comment to Sample: It has sometimes been claimed that the collection of blood samples violates the tenets of certain religious or cultural groups. It has been determined that there is no basis for any such claim.]

Target Testing. Selection of Athletes for Testing where specific Athletes or groups of Athletes are selected on a non‐random basis for Testing at a specified time.

Testing. The parts of the Doping Control process involving test distribution planning, Sample collection, Sample handling, and Sample transport to the laboratory.

For further definition please read the IBU ADR - Appendix 1 available on this web site